Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 270

    1.

    A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding.

    Liang K, Gui X, Zhang YZ, Zhuang K, Meyers K, Ho DD.

    J Infect Dis. 2009 Sep 1;200(5):682-6.PMID: 19627245 [PubMed - indexed for MEDLINE]Related articles

    2.

    A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.

    Gardiner DF, Rosenberg T, Zaharatos J, Franco D, Ho DD.

    Vaccine. 2009 Jun 2;27(27):3598-604. Epub 2009 Apr 9.PMID: 19464540 [PubMed - indexed for MEDLINE]Related articles

    3.

    The changing face of HIV in China.

    Lu L, Jia M, Ma Y, Yang L, Chen Z, Ho DD, Jiang Y, Zhang L.

    Nature. 2008 Oct 2;455(7213):609-11.PMID: 18833270 [PubMed - indexed for MEDLINE]Related articles

    4.

    A recoding method to improve the humoral immune response to an HIV DNA vaccine.

    Huang Y, Krasnitz M, Rabadan R, Witten DM, Song Y, Levine AJ, Ho DD, Robins H.

    PLoS One. 2008 Sep 15;3(9):e3214.PMID: 18791646 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.

    Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, Wong CH, Ho DD.

    Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13538-43. Epub 2008 Sep 2.PMID: 18765801 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    HIV-1 at 25.

    Ho DD, Bieniasz PD.

    Cell. 2008 May 16;133(4):561-5.PMID: 18485860 [PubMed - indexed for MEDLINE]Related articles

    7.

    Isolation and quantitation of HIV in peripheral blood.

    Koup RA, Ho DD, Poli G, Fauci AS.

    Curr Protoc Immunol. 2001 May;Chapter 12:Unit 12.2.PMID: 18432710 [PubMed - indexed for MEDLINE]Related articles

    8.

    Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.

    Huang Y, Chen A, Li X, Chen Z, Zhang W, Song Y, Gurner D, Gardiner D, Basu S, Ho DD, Tsuji M.

    Vaccine. 2008 Mar 28;26(15):1807-16. Epub 2008 Feb 20.PMID: 18329757 [PubMed - indexed for MEDLINE]Related articles

    9.

    Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.

    Huang Y, Chen Z, Zhang W, Gurner D, Song Y, Gardiner DF, Ho DD.

    J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):403-11.PMID: 18209683 [PubMed - indexed for MEDLINE]Related articles

    10.

    Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'.

    Chen Z, Huang Y, Zhao X, Ba L, Zhang W, Ho DD.

    J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):412-21.PMID: 18209682 [PubMed - indexed for MEDLINE]Related articles

    11.

    Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.

    Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L.

    Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19079-84. Epub 2007 Nov 19.PMID: 18025463 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.

    Ba L, Yi CE, Zhang L, Ho DD, Chen Z.

    Appl Microbiol Biotechnol. 2007 Oct;76(5):1131-6. Epub 2007 Jun 21.PMID: 17581748 [PubMed - indexed for MEDLINE]Related articles

    13.

    Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

    Janowicz DM, Tenner-Racz K, Racz P, Humphreys TL, Schnizlein-Bick C, Fortney KR, Zwickl B, Katz BP, Campbell JJ, Ho DD, Spinola SM.

    J Infect Dis. 2007 May 15;195(10):1443-51. Epub 2007 Apr 5.PMID: 17436224 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.

    Liu L, Fang Q, Deng F, Wang H, Yi CE, Ba L, Yu W, Lin RD, Li T, Hu Z, Ho DD, Zhang L, Chen Z.

    J Virol. 2007 May;81(9):4694-700. Epub 2007 Feb 21.PMID: 17314167 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.

    Zhang Y, Lu L, Ba L, Liu L, Yang L, Jia M, Wang H, Fang Q, Shi Y, Yan W, Chang G, Zhang L, Ho DD, Chen Z.

    PLoS Med. 2006 Nov;3(11):e443.PMID: 17105339 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

    Simon V, Ho DD, Abdool Karim Q.

    Lancet. 2006 Aug 5;368(9534):489-504. Review.PMID: 16890836 [PubMed - indexed for MEDLINE]Related articles

    17.

    Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

    Fujio M, Wu D, Garcia-Navarro R, Ho DD, Tsuji M, Wong CH.

    J Am Chem Soc. 2006 Jul 19;128(28):9022-3.PMID: 16834361 [PubMed - indexed for MEDLINE]Related articles

    18.

    Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

    Simon V, Zennou V, Murray D, Huang Y, Ho DD, Bieniasz PD.

    PLoS Pathog. 2005 Sep;1(1):e6. Epub 2005 Jul 22.PMID: 16201018 [PubMed]Related articlesFree article

    20.

    Multiple-site DNA vaccination enhances immune responses in mice.

    Gardiner DF, Huang Y, Basu S, Leung L, Song Y, Chen Z, Ho DD.

    Vaccine. 2006 Jan 16;24(3):287-92. Epub 2005 Aug 8.PMID: 16137804 [PubMed - indexed for MEDLINE]Related articles

    21.

    SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.

    Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY.

    Vaccine. 2005 Oct 10;23(42):4959-68.PMID: 15993989 [PubMed - indexed for MEDLINE]Related articles

    22.

    Duration of an intermittent episode of viremia.

    Di Mascio M, Percus JK, Percus OE, Markowitz M, Ho DD, Perelson AS.

    Bull Math Biol. 2005 Jul;67(4):885-900.PMID: 15893558 [PubMed - indexed for MEDLINE]Related articles

    23.

    In vivo replication kinetics of a nef-deleted strain of HIV-1.

    Crowe SM, Ho DD, Marriott D, Brew B, Gorry PR, Sullivan JS, Learmont J, Mills J.

    AIDS. 2005 May 20;19(8):842-3. No abstract available. PMID: 15867504 [PubMed - indexed for MEDLINE]Related articles

    24.

    Recognition of bacterial glycosphingolipids by natural killer T cells.

    Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M.

    Nature. 2005 Mar 24;434(7032):520-5.PMID: 15791257 [PubMed - indexed for MEDLINE]Related articles

    25.

    Identification of microRNAs of the herpesvirus family.

    Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T.

    Nat Methods. 2005 Apr;2(4):269-76. Epub 2005 Feb 16.PMID: 15782219 [PubMed - indexed for MEDLINE]Related articles

    26.

    Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides.

    Xing GW, Wu D, Poles MA, Horowitz A, Tsuji M, Ho DD, Wong CH.

    Bioorg Med Chem. 2005 Apr 15;13(8):2907-16.PMID: 15781400 [PubMed - indexed for MEDLINE]Related articles

    27.

    Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

    Markowitz M, Mohri H, Mehandru S, Shet A, Berry L, Kalyanaraman R, Kim A, Chung C, Jean-Pierre P, Horowitz A, La Mar M, Wrin T, Parkin N, Poles M, Petropoulos C, Mullen M, Boden D, Ho DD.

    Lancet. 2005 Mar 19-25;365(9464):1031-8.PMID: 15781098 [PubMed - indexed for MEDLINE]Related articles

    28.

    A shot in the arm for AIDS vaccine research.

    Ho DD.

    PLoS Med. 2005 Feb;2(2):e36. Epub 2005 Jan 18. No abstract available. Erratum in: PLoS Med. 2005 Aug;2(8):e299. PMID: 15740412 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

    Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD.

    J Virol. 2005 Mar;79(5):2678-88.PMID: 15708987 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.

    Wu D, Xing GW, Poles MA, Horowitz A, Kinjo Y, Sullivan B, Bodmer-Narkevitch V, Plettenburg O, Kronenberg M, Tsuji M, Ho DD, Wong CH.

    Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1351-6. Epub 2005 Jan 21.PMID: 15665086 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus.

    Arron ST, Ribeiro RM, Gettie A, Bohm R, Blanchard J, Yu J, Perelson AS, Ho DD, Zhang L.

    Eur J Immunol. 2005 Jan;35(1):46-55.PMID: 15593297 [PubMed - indexed for MEDLINE]Related articles

    32.

    Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.

    Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, Yin N, Mei S, Li L, Balfe P, He T, Ba L, Zhang F, Lin HH, Yuen MF, Lai CL, Ho DD.

    J Virol. 2004 Dec;78(24):13591-9.PMID: 15564470 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

    Kao RY, Tsui WH, Lee TS, Tanner JA, Watt RM, Huang JD, Hu L, Chen G, Chen Z, Zhang L, He T, Chan KH, Tse H, To AP, Ng LW, Wong BC, Tsoi HW, Yang D, Ho DD, Yuen KY.

    Chem Biol. 2004 Sep;11(9):1293-9.PMID: 15380189 [PubMed - indexed for MEDLINE]Related articles

    34.

    Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection.

    Di Mascio M, Markowitz M, Louie M, Hurley A, Hogan C, Simon V, Follmann D, Ho DD, Perelson AS.

    J Virol. 2004 Oct;78(19):10566-73.PMID: 15367623 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

    McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.

    J Virol. 2004 Aug;78(16):8496-505.PMID: 15280458 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy.

    Dixit NM, Markowitz M, Ho DD, Perelson AS.

    Antivir Ther. 2004 Apr;9(2):237-46.PMID: 15134186 [PubMed - indexed for MEDLINE]Related articles

    37.

    HIV-1 dynamics in vivo: implications for therapy.

    Simon V, Ho DD.

    Nat Rev Microbiol. 2003 Dec;1(3):181-90. Review.PMID: 15035022 [PubMed - indexed for MEDLINE]Related articles

    38.

    Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.

    Di Mascio M, Ribeiro RM, Markowitz M, Ho DD, Perelson AS.

    Math Biosci. 2004 Mar-Apr;188:47-62.PMID: 14766093 [PubMed - indexed for MEDLINE]Related articles

    39.

    Retraction of an interpretation.

    Zhang L, Lopez P, He T, Yu W, Ho DD.

    Science. 2004 Jan 23;303(5657):467. No abstract available. PMID: 14739439 [PubMed - indexed for MEDLINE]Related articles

    40.

    Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication.

    Ramratnam B, Ribeiro R, He T, Chung C, Simon V, Vanderhoeven J, Hurley A, Zhang L, Perelson AS, Ho DD, Markowitz M.

    J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):33-7.PMID: 14707789 [PubMed - indexed for MEDLINE]Related articles

    41.

    Viral blip dynamics during highly active antiretroviral therapy.

    Di Mascio M, Markowitz M, Louie M, Hogan C, Hurley A, Chung C, Ho DD, Perelson AS.

    J Virol. 2003 Nov;77(22):12165-72.PMID: 14581553 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.

    Chang TL, Chang CH, Simpson DA, Xu Q, Martin PK, Lagenaur LA, Schoolnik GK, Ho DD, Hillier SL, Holodniy M, Lewicki JA, Lee PP.

    Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11672-7. Epub 2003 Sep 12.PMID: 12972635 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Estimating average cellular turnover from 5-bromo-2'-deoxyuridine (BrdU) measurements.

    De Boer RJ, Mohri H, Ho DD, Perelson AS.

    Proc Biol Sci. 2003 Apr 22;270(1517):849-58.PMID: 12737664 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy.

    Percus JK, Percus OE, Markowitz M, Ho DD, Di Mascio M, Perelson AS.

    Bull Math Biol. 2003 Mar;65(2):263-77.PMID: 12675332 [PubMed - indexed for MEDLINE]Related articles

    45.

    A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.

    Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD.

    J Virol. 2003 Apr;77(8):5037-8.PMID: 12663814 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Determining the relative efficacy of highly active antiretroviral therapy.

    Louie M, Hogan C, Di Mascio M, Hurley A, Simon V, Rooney J, Ruiz N, Brun S, Sun E, Perelson AS, Ho DD, Markowitz M.

    J Infect Dis. 2003 Mar 15;187(6):896-900. Epub 2003 Mar 6.PMID: 12660935 [PubMed - indexed for MEDLINE]Related articles

    47.

    Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.

    De Boer RJ, Mohri H, Ho DD, Perelson AS.

    J Immunol. 2003 Mar 1;170(5):2479-87.PMID: 12594273 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.

    Jin X, Gao X, Ramanathan M Jr, Deschenes GR, Nelson GW, O'Brien SJ, Goedert JJ, Ho DD, O'Brien TR, Carrington M.

    J Virol. 2002 Dec;76(24):12603-10.PMID: 12438586 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

    Ribeiro RM, Mohri H, Ho DD, Perelson AS.

    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15572-7. Epub 2002 Nov 14.PMID: 12434018 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

    Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD.

    Science. 2002 Nov 1;298(5595):995-1000. Epub 2002 Sep 26. Retraction in: Zhang L, Lopez P, He T, Yu W, Ho DD. Science. 2004 Jan 23;303(5657):467. PMID: 12351674 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...